Sanjive Qazi Selected Research

Catheters

11/2019

Recurrent or Refractory High-Grade Gliomas Treated by Convection-Enhanced Delivery of a TGFβ2-Targeting RNA Therapeutic: A Post-Hoc Analysis with Long-Term Follow-Up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanjive Qazi Research Topics

Disease

16	Neoplasms (Cancer) 03/2024 - 01/2004
13	Leukemia 03/2023 - 01/2010
13	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2010
5	Lymphoma (Lymphomas) 04/2023 - 02/2010
4	Glioma (Gliomas) 03/2024 - 11/2019
4	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2004
4	Acquired Immunodeficiency Syndrome (AIDS) 04/2012 - 11/2002
3	Multiple Myeloma 06/2023 - 01/2019
3	Glioblastoma (Glioblastoma Multiforme) 03/2023 - 01/2007
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 12/2019
2	Carcinogenesis 01/2020 - 01/2020
2	Inflammation (Inflammations) 01/2010 - 02/2008
1	Brain Stem Neoplasms (Brain Stem Tumor) 01/2024
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2023
1	Diffuse Intrinsic Pontine Glioma 03/2023
1	Sepsis (Septicemia) 10/2022
1	Astrocytoma (Pilocytic Astrocytoma) 11/2019
1	Cytokine Release Syndrome 01/2018
1	Philadelphia Chromosome 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Residual Neoplasm 04/2015
1	Polyploidy 11/2014
1	Genetic Translocation (Chromosomal Translocation) 01/2013
1	Weight Loss (Weight Reduction) 01/2011
1	Paralysis (Palsy) 01/2011
1	Diarrhea 01/2011
1	Lethargy 01/2011
1	Hyperplasia 09/2010
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2010
1	Skin Neoplasms (Skin Cancer) 01/2010
1	Melanoma (Melanoma, Malignant) 01/2010
1	Sunburn 01/2010
1	Peritonitis 02/2008
1	Cellulitis 02/2008
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 02/2008
1	Colitis 02/2008

Drug/Important Bio-Agent (IBA)

7	Phosphotransferases (Kinase)IBA 12/2022 - 01/2007
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2010
6	Tyrosine (L-Tyrosine)FDA Link 12/2022 - 01/2007
5	Messenger RNA (mRNA)IBA 03/2024 - 03/2023
5	WHI P131IBA 01/2020 - 01/2007
4	Transforming Growth Factor beta (TGF-beta)IBA 03/2024 - 01/2018
4	RNA (Ribonucleic Acid)IBA 06/2023 - 07/2015
4	Syk KinaseIBA 06/2015 - 02/2010
3	stampidineIBA 01/2020 - 11/2002
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 01/2007
3	Phosphates (Orthophosphate)IBA 01/2020 - 11/2002
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2007
2	Interferon gamma ReceptorIBA 03/2024 - 01/2024
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2018
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2023 - 01/2022
2	Transcription Factors (Transcription Factor)IBA 03/2023 - 01/2013
2	Stavudine (Zerit)FDA LinkGeneric 01/2020 - 11/2002
2	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2020 - 01/2020
2	CytokinesIBA 01/2018 - 01/2011
2	Anti-Infective Agents (Microbicides)IBA 03/2012 - 12/2002
2	LFM A13IBA 01/2011 - 01/2007
2	Janus Kinase 3IBA 01/2010 - 01/2007
1	AntigensIBA 03/2024
1	LigandsIBA 03/2024
1	Interferon Regulatory FactorsIBA 03/2024
1	Interferon-gamma (Interferon, gamma)IBA 01/2024
1	Transforming Growth Factor beta3 (TGF beta 3)IBA 03/2023
1	dipinacoline glutamateIBA 03/2023
1	Indicators and Reagents (Reagents)IBA 03/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022
1	GalactosamineIBA 10/2022
1	ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combinationIBA 10/2022
1	polypeptide 1 70kD ribosomal protein S6 kinaseIBA 01/2020
1	combretastatin A-1IBA 12/2019
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2019
1	Oxi 4503IBA 12/2019
1	Diphosphates (Pyrophosphates)IBA 12/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	ChemokinesIBA 01/2018
1	Peptides (Polypeptides)IBA 12/2014
1	Small Interfering RNA (siRNA)IBA 12/2014
1	NocodazoleIBA 11/2014
1	Monoclonal AntibodiesIBA 08/2014
1	DisulfidesIBA 01/2013
1	Immunoconjugates (Immunoconjugate)IBA 01/2013
1	Ikaros Transcription FactorIBA 01/2013
1	OligonucleotidesIBA 01/2013
1	E2A-Pbx1 fusion proteinIBA 01/2013
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 04/2012
1	HI 443IBA 03/2012
1	Vincristine (Oncovin)FDA LinkGeneric 01/2011
1	Agammaglobulinaemia Tyrosine KinaseIBA 11/2010
1	RNA Precursors (Precursor, mRNA)IBA 09/2010
1	RNA Splicing FactorsIBA 09/2010
1	Heterogeneous-Nuclear Ribonucleoprotein LIBA 09/2010
1	Tyrosine Kinase InhibitorsIBA 01/2010

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2020 - 11/2006
4	Therapeutics 06/2023 - 12/2014
1	Chemoprevention 01/2020
1	Catheters 11/2019
1	Radiotherapy 06/2015
1	Hematopoietic Stem Cell Transplantation 04/2015
1	RNAi Therapeutics 12/2014
1	Topical Administration 01/2010